Neurotron, Incorporated Innovative Medical Technology Established 1981 |
||
Neurometer® Clinical Nephrology Applications |
|
---|
Nephrologists use sNCT/CPT studies to evaluate patients with kidney disease to assist in determining when to commence dialysis therapy. The study is prescribed when clinical examination findings suggest development of an impairment in distal sensory function and an objective evaluation is required to confirm and evaluate a diagnosis of polyneuropathy. Typically, the distal great toe test site is tested bilaterally and if a polyneuropathy is detected then dialysis therapy may be considered to attempt to reverse the condition and/or prevent its progression. Normal sNCT/CPT evaluation results indicate that no further sNCT/CPT testing is necessary unless a change in the clinical condition suggesting sensory dysfunction requires an evaluation. Nephrologists also prescribe the sNCT/CPT study to be administered to endstage renal disease patients to provide an index of the long-term adequacy of dialysis therapy.
|
The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated
Est. 1981, Baltimore, MD, USA. All rights reserved, worldwide
rev 10/16/09 |